VET THERAPEUTICS
Vet Therapeutics is developing antibody-based therapies to treat pet cancer and chronic conditions. The company is committed to bringing the same modality of products that constitute the standard of care in humans to animal health by applying world-class science to new products for companion animals. The Vet Therapeutics team has more than 30 years' experience and a successful track record at developing antibody-based biologics for humans, which is directed towards the development of pet-specific biologics to treat pet cancer and chronic conditions.
VET THERAPEUTICS
Industry:
Biotechnology
Founded:
2008-01-01
Address:
Del Mar, California, United States
Country:
United States
Website Url:
http://www.vettherapeutics.com
Total Employee:
1+
Status:
Closed
Contact:
858-361-0393
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright
Similar Organizations
Comet Therapeutics
Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.
Tavec pharma
Tavec Pharmaceuticals is developing injectable therapies to treat cancers.
Vetigenics
Vetigenics discovers and develops antibody-based immunotherapies to treat cancer and chronic diseases in companion animals
Official Site Inspections
http://www.vettherapeutics.com
- Host name: ec2-3-130-253-23.us-east-2.compute.amazonaws.com
- IP address: 3.130.253.23
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Vet Therapeutics"
Vet Therapeutics - Crunchbase Company Profile
Vet Therapeutics is developing antibody-based therapies to treat pet cancer and chronic conditions. The company is committed to bringing the same modality …See details»
Vet Therapeutics Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for Vet Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Vet Therapeutics Inc - Company Profile and News
Vet Therapeutics Inc. develops antibody-based therapies to treat pet cancer and chronic conditions. The Company develops a canine monoclonal antibody for the treatment of B-cell …See details»
VET THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VET THERAPEUTICS, INC. of Del Mar, CA. Get the latest business insights from Dun & Bradstreet.See details»
Vet Therapeutics - Products, Competitors, Financials, Employees ...
Vet Therapeutics is developing antibody-based therapies to treat pet cancer and chronic conditions. Use the CB Insights Platform to explore Vet Therapeutics's full profile.See details»
Vet Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
Explore Vet Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Vet Therapeutics, Inc. Company Profile -Sales, Contacts, …
Vet Therapeutics, Inc. is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in …See details»
Vet Therapeutics - Crunchbase
Vet Therapeutics is developing antibody-based therapies to treat pet cancer and chronic conditions.See details»
VET THERAPEUTICS, INC. - VentureRadar
Vet therapeutics, inc. VentureRadar profile. Find out more about VET THERAPEUTICS, INC. including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Vet Therapeutics, Inc. Asset Profile | Preqin
Vet Therapeutics, Inc. is based in Del Mar, US and is the leading company in the development of antibody-based therapies to treat pet cancer and chronic conditions.See details»
Vet Therapeutics - Ownership and Business Overview - Mergr
Oct 14, 2013 · Who owns Vet Therapeutics? Vet Therapeutics is owned by Aratana Therapeutics. It was acquired on October 14, 2013.See details»
Aratana Agrees to Acquire Vet Therapeutics, Inc. - PR Newswire
Oct 14, 2013 · Under the agreement, Aratana plans to continue to advance the pipeline of high value biologic drugs, including its lymphoma franchise. Importantly, the acquisition of Vet …See details»
Companion therapeutics - Nature Biotechnology
Jan 9, 2014 · Vet Therapeutics uses a proprietary antibody platform to design and develop animal-specific antibodies.See details»
Recombinant Antibodies in Veterinary Medicine: An Update
Hybrid rAbs, chimeric or “–nized,” are common in veterinary medicine. A chimeric Ab typically consists of the V regions of one Ab and the C region of another. The “–nized” Ab comprises …See details»
Home - Modern Veterinary Therapeutics
Explore our diverse portfolio of trusted therapeutics, designed to meet the highest standards of excellence, categorized by species. As a company driven by innovation, we continuously …See details»
Aratana Agrees to Acquire Vet Therapeutics, Inc.
Oct 14, 2013 · Under the terms of the merger agreement for the Vet Therapeutics acquisition, Aratana agreed to pay to Vet Therapeutics' equity holders at the closing $30 million in cash, …See details»
Cell Therapy in Veterinary Medicine as a Proof-of-Concept for …
In the past decade, the potential to translate scientific discoveries in the area of regenerative therapeutics in veterinary species to novel, effective human therapies has gained interest from …See details»
2022 Veterinary Therapeutics: Highlights & Practical Considerations
From updated indications to human drugs approved for use in veterinary medicine, catch up on everything to know about updates and highlights in therapeutics in 2022.See details»
A history of antimicrobial drugs in animals: Evolution and …
The United Nations involvement with AMD and AMR is channelled through two organizations, namely the Food and Agriculture Organization (FAO) and the World Health Organization …See details»
12 Veterinarian Resume Examples - huntr.co
1 day ago · The certifying organization; The date you obtained the certification; The expiration date (if applicable) Tips for an Effective Veterinarian Resume. To create a standout …See details»